Special Issue "Poxvirus"
Deadline for manuscript submissions: closed (15 May 2022) | Viewed by 12439
Interests: viral vaccines; viral diagnostics; nanomaterials applied to viral biotechnologies
Special Issues, Collections and Topics in MDPI journals
Special Issue in Viruses: Viral Infections in Developing Countries
Special Issue in Viruses: Viral Infections in Developing Countries, Volume II
Topical Collection in Viruses: Poxviruses
Special Issue in Viruses: Nanomedicine Applied in the Control and Diagnosis of Viral Infections
Interests: Orthopoxvirus; vaccinia virus; giant viruses; yellow fever virus; dengue virus, Zika virus
Poxviruses have been at the very center of virology science development since its first years. Poxviruses were also present at the birth of vaccinology, and smallpox is the only human virus, to date, to be eradicated through a vaccination campaign. Viruses belonging to the Poxvirus family were among the first to be chemically characterized, grown in cell culture, purified, and accurately titrated. Moreover, poxviruses were also among the first to be used as biotechnological tools for the expression of heterologous proteins in mammalian cells. Today, poxviruses are still viewed as iconic viruses and are studied in a multitude of different contexts. This Special Issue aims to publish all types of manuscripts (i.e., reviews, research articles, and short communications) covering a wide range of topics related to poxviruses, including but not limited to the biology of poxviruses, pathogenesis of poxviruses and virus–host interactions, immune responses to poxviruses, ecology of poxviruses, identification of new species and/or new poxvirus variants, use of poxviruses as biotechnological tools, poxvirus-based vaccines, and oncolytic poxviruses
Dr. Flavio Guimaraes da Fonseca
Dr. Erna G. Kroon
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccinia virus
- oncolytic viruses
- emergent viruses
- vaccine vectors
- nucleocytoplasmic large DNA viruses (NCLDV)
- oncolytic virus therapy